JNJ
JNJ Approaching Support, Potential Bounce! JNJ is approaching our first support at 117.78 (horizontal overlap support, 100% fibonacci extension, 50%, 23.6% fibonacci retracement) where a strong bounce could occur above this level pushing price up to our major resistance at 136.78 (horizontal pullback resistance, 61.8% fibonacci retracement, 61.8% fibonacci extension).
Stochastic (89,5,3) is also approaching support where we might see a corresponding bounce in price.
JNJ Approaching Resistance, Potential Drop! JNJ is approaching our first resistance at 132.37 (horizontal pullback resistance, 61.8% Fibonacci extension, 23.6% Fibonacci retracement) where a strong drop might occur below this level pushing price down to our major support at 119.46 (horizontal swing low support, 100% Fibonacci extension).
RSI (89) is also seeing a bearish exit and we might see a corresponding drop in price.
JNJ 60 Min - Bullish Cypher Pattern - Long SetupJNJ 60 Min Bullish Cypher Pattern - Long Setup
Bullish Cypher has been detected on JNJ 60 Min.
Price bounced several times about 141.95
Enter LONG JNJ at @ 142.7 with a stop loss going at @ 141.0. The first target is at @ 144.5 and the second target is at @ 146.20.
Enjoy our limited Content and Setups,
leave us a like and Comment!!
JNJ: All roads lead to 147It is crystal clear from this chart and various types of analysis that JNJ is in a zone that will probably lead to at least the 147 range. We can see a shaded channel that the stock has been ascending in for several months. We can also see that volume has been steadily increasing at a sustainable pace. From the wave count (please study Elliot Wave theory if you don't understand this) it is clear that there is a 70% chance JNJ will top out between 148.28 and 156.58 using Fibonacci levels derived from wave 3- trough to peak, and wave 4- peak to trough. Based on the standard assumption that the fifth wave will be more or less equal to the first in magnitude this would project a conservative target of at least 147 coinciding with the channel. Lastly please note that stocks and markets in general respect support and resistance levels- not specific time frames with the point being that I don't know when this price will likely be reached, just that its probably coming. Needless to day nothing is ever certain in trading so always manage risk and deal in probabilities, good luck.
Please feel free to leave feedback, questions and criticisms welcome.
JNJ - 10% Upside OpportunityPrice is showing sign of a completed ending diagonal structure.
We are looking for price to move higher from here potentially towards 133.43 - 136.93 area.
**Disclaimer - This analysis alone DOES NOT warrant a sell trade immediately. Before you enter any trade in the financial market, it is very important that you have a proper trading plan and risk management approach.
The sharing of this idea is neither necessarily indicative of nor a guarantee of future performance or success.
Johnson & Johnson (NYSE: JNJ)_May_08_2018JNJ has had a good run since the beginning of 2017. Although, the stock price has dropped from a high of $148 to $122, I think reality is catching up with investors that equity valuations have been quite expensive and that it is time for some correction. I believe the fundamentals of the company remain strong although the liabilities with rising interest rates may be a cause for concern.
I believe the current scenario presents an opportunity to short the stock. Based on the head the shoulder pattern, the price is expected to drop to $110-$115 range.
JNJLong JNJ via short put spread.
Short Mar16 125/130 put spread for $1.10.
POP: 69%
BPR: $390
Max loss: $390
Max Win: $110
Target: 50-60% of credit received
Stop loss: Price at $127 or $350ish loss.
short 130 put: 37 delta
long 125 put: 15 delta
If this starts to get really ugly, I may pull off before $127.
JNJ: another fallen giantJNJ is yet another giant trading under the 200SMA.
Even though we had a strong earnings beat last week JNJ was not protected from the dip.
When the inevitable bottom is formed, I will be looking at these large caps under the 200 for bargain buys.
Hard to say what the near term status is for JNJ, following that of the market.
I would be looking for buys in the $122 range.
JNJ put saleJNJ had a massive move down on their earnings. This is one of the largest candles I can even find on the chart for JNJ. As is approached the 50EMA I was looking for Bull Put Spread or Put Sale premium. Because of dividends being at the end of February and the 200 SMA down around 134. It seems like a no brainer.
October 17 Earnings: Johnson&Johnson- Generic Competition GaloreJohnson & Johnson has been on an impressive intra-quarterly run with solid performance across major segments.
Strengths in the company's performance are to be driven by:
-Imbruvica and Darzalex should continue to perform well. Meaningful improvement from Stelara and Xarelto.
-New product launches like Tremfy (approved in the US late 2017 for plaque psoriasis)
-Revenue contribution from Swiss biotech Actelion, which J&J bought in June.
-Medical devices segment is expected to continue its strong growth trajectory with new product launches.
Weaknesses for the quarter are expected to be:
-Key arthritis drug Remicade to remain under pressure from generic competition.
-Invokana hurting from higher managed care discounting.
-Sluggish FDA review requiring more information before approving new drug treatments.
-Lawsuit from Pfizer to be clarified during the conference call.
Overall, I believe high expenses and generic competition will overcome the positives for the quarter.
I'm starting Johnson&Johnson with a $130 PT for the post earnings move with a tight but flexible 2.5% stop.